Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue
hypoperfusion that may result in end-organ dysfunction and death. CS is associated with …

As a consequence, extended recommendations to younger and lower risk patients seem
inevitable, while newer indications for intervention in asymptomatic patients, those with pure …

Aims Patients with aortic stenosis (AS) and cardiogenic shock (CS) are an extremely high-
risk population with a poor prognosis in the absence of definitive therapy. We aimed to …

Introduction Over the course of 2021, numerous key clinical trials with valuable contributions
to clinical cardiology were published or presented at major international conferences. This …

Pathologic left ventricular remodeling and valvular heart disease may contribute to the
clinical presentation and outcomes of patients presenting with heart failure, and limit the …

University of Zurich in Switzerland, and colleagues. 1 The authors point out that cardiogenic
shock (CS) remains the primary cause of inhospital death after acute coronary syndromes …

The clinical presentation of severe aortic valve stenosis (AS) ranges from asymptomatic to
symptomatic. Timely referral and work-up for valve replacement therapy are crucial to …

Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute
heart failure. In acute heart failure caused by VHD, symptoms result from rapid …

Like last year, we had the difficult task to select the 10 best papers on valvular heart disease
published in 2023. We restricted our selection to publications in the New England Journal of …